U.S. Biotech Stock News

Analyst downgrades put monday.com (MNDY) back under the microscope A cluster of analyst downgrades, including Jefferies shifting monday.com from Buy to Hold with a sharply reduced price target, has put the stock back in focus for investors who are weighing recent sentiment against guidance and fundamentals. See our latest analysis for monday.com. The recent stream of analyst downgrades has landed on a stock already under pressure, with a 30 day share price return of 42.86% decline and a year...

DMC Global Inc. has reported its fourth-quarter 2025 results, with sales falling to US$143.53 million from US$152.37 million a year earlier and swinging from a small net income to a net loss of US$11.16 million. For full-year 2025, the company reduced its net loss to US$13.45 million despite lower sales of US$609.84 million, but management’s first-quarter 2026 guidance flags continued operational pressures and weather-related disruptions that are expected to weigh on near-term...

What Phillips 66’s recent performance tells investors Phillips 66 (PSX) has drawn fresh attention after a period where the stock showed mixed short term moves, with a 1 day decline, a weaker past week, yet positive month and past 3 months returns. See our latest analysis for Phillips 66. Looking beyond the recent pullback, Phillips 66’s share price has risen from shorter term strength, with a 30 day share price return of 8.2% and year to date share price return of 16.3%, while the 1 year...

In February 2026, Lincoln Educational Services reported Q4 2025 and full‑year results showing higher revenue of US$142.87 million for the quarter and US$518.24 million for the year, alongside net income of US$12.7 million and US$20 million respectively, and issued 2026 guidance calling for revenue of US$580–590 million and diluted EPS of US$0.64–0.74. Beyond the headline earnings beat, management highlighted double‑digit student start growth, rising operating efficiency, and planned campus...

In late February 2026, Hims & Hers Health reported fourth-quarter 2025 results showing higher sales year on year but slightly lower quarterly profit, issued softer-than-expected Q1 2026 revenue guidance amid regulatory and legal pressure on its compounded semaglutide weight-loss offerings, and filed a US$176.23 million shelf registration tied to an ESOP-related Class A share offering. The company’s outlook now hinges on how it manages FDA scrutiny, a Novo Nordisk patent lawsuit, an SEC...

What recent returns say about Amprius Technologies Amprius Technologies (AMPX) has drawn fresh attention after a strong year, with the stock showing a year to date return of 26.5% and a 1 year total return that is very large. In the shorter term, the share price shows a 2.4% move over the past day, about 11.6% over the past week, and modest gains over the past month and past 3 months, giving investors several different entry points to compare. See our latest analysis for Amprius...

In the fourth quarter and full year ended December 31, 2025, CBRE Group reported higher sales but lower quarterly earnings per share, while also completing a share repurchase program totaling 43,753,374 shares for about US$4.20 billion since its November 2021 authorization. Alongside this capital return, a series of analyst upgrades highlighting CBRE’s positioning for artificial intelligence and resilient brokerage trends has reframed how investors view the company’s longer-term earnings...

In February 2026, Intuit Inc. announced a multi-year partnership with Anthropic to embed Claude-powered custom AI agents across its platform and to surface Intuit’s tax, accounting, finance, and marketing tools directly inside Anthropic products such as Cowork, Claude for Enterprise, and Claude.ai. This collaboration is set to let even non-technical mid-market businesses design compliant, workflow-specific AI agents that pull together Intuit and third-party data to automate complex financial...

Phibro Animal Health (NasdaqGM:PAHC) CEO Jack Bendheim recently sold a substantial block of company shares. The sale followed a strong quarterly performance for Phibro Animal Health. Growth in the Medicated Feed Additives portfolio, supported by recent acquisitions, was a key driver in the latest results. The timing of the insider sale after reported operational progress has drawn attention from investors tracking management actions. Phibro Animal Health focuses on animal health and...

Gladstone Land (LAND) has wrapped up FY 2025 with Q4 total revenue of US$41.6 million, a basic EPS loss of US$0.05, and a net income loss of US$1.8 million, alongside funds from operations of US$0.5 million in losses. Over the last few reported periods, revenue has moved from US$21.2 million in Q4 2024 to US$41.6 million in Q4 2025. Trailing twelve month revenue for the year to Q4 2025 sits at US$88.3 million and basic EPS on the same basis is a loss of US$0.29. For investors, these results...

In February 2026, Visa Inc. expanded its global partnership with Oracle Red Bull Racing and Visa Cash App Racing Bulls while also issuing US$3.00 billion of senior notes maturing between 2029 and 2036 and entering a European e‑invoicing payments collaboration with Banqup SA. At the same time, Visa has been pulled into debates over AI- and stablecoin-driven disruption, regulatory scrutiny in Mexico and the US, and a major swipe-fee settlement, highlighting both its reach and the growing...

Lumentum Holdings (NasdaqGS:LITE) has reported accelerating demand for its Optical Circuit Switches and co packaged optics. The company has received significant new multi million dollar purchase orders and is reporting a record backlog tied to AI focused optical networking projects. Management has outlined clearer multi year deployment cycles for these technologies as they are adopted in data center networks. Lumentum Holdings, trading under NasdaqGS:LITE, is drawing fresh attention as its...

If you are wondering whether Intapp is starting to look interesting at its current share price, you are not alone and this article is designed to help you weigh that up. The stock has recently seen a 5.2% decline over the last week, a 44.9% decline over the last month and a 67.3% decline over the past year, which will naturally raise questions about both risk and potential future returns. These moves sit against a backdrop of ongoing coverage of Intapp as a listed software company, with...

Jazz Pharmaceuticals (JAZZ) just released its FY 2025 numbers, reporting Q4 revenue of US$1.2 billion and basic EPS of US$3.33, alongside trailing 12 month revenue of US$4.3 billion and a basic EPS loss of US$5.84. Over recent quarters, the company has reported revenue in a range from US$897.8 million in Q1 2025 to US$1.2 billion in Q4 2025, while quarterly basic EPS has moved between a loss of US$11.74 and a profit of US$4.14. This sets up a story where investors are weighing sizeable top...

Why NIO’s latest battery swap records matter for shareholders NIO (NIO) is back in focus after setting fresh records for its battery swap service during the Lunar New Year holiday, hitting 1 million swaps in under a week and multiple single day highs. For you as an investor, this surge in usage puts a spotlight on NIO’s Battery as a Service subscription model, its expanding nationwide infrastructure in China, and management’s expectation of achieving its first adjusted operational profit in...

Energy Transfer (NYSE:ET) raised its 2026 adjusted EBITDA guidance and outlined higher planned growth capital expenditures of US$5b to US$5.5b. The company reported progress on several large natural gas infrastructure projects, supported by acquisitions through subsidiaries, including USA Compression. Management highlighted substantial volume growth tied to data center and power generation demand, alongside an updated distribution growth outlook. Energy Transfer operates a large midstream...

Doximity (DOCS) has drawn investor attention after a steep share price pullback, with the stock showing declines over the month, the past 3 months, year to date and over the past year. See our latest analysis for Doximity. At a share price of US$24.40, Doximity’s recent momentum has clearly faded, with a 30 day share price return of 39.6% and a 1 year total shareholder return of 66.5%. This suggests sentiment has shifted sharply despite its established position in digital tools for medical...

In January 2026, XPeng’s vehicle deliveries dropped to 20,011 units from 37,508 in December, while law firm Pomerantz LLP began investigating potential securities law violations, adding legal uncertainty to existing operational pressures in China’s crowded EV market. This combination of weaker delivery volumes and fresh legal scrutiny has sharpened investor focus on XPeng’s ability to sustain demand, protect margins, and manage regulatory risk as competition intensifies. We’ll now examine...

Somnigroup International Inc. recently reported fourth quarter and full-year 2025 results, with quarterly sales rising to US$1,868.4 million and net income to US$140.8 million, while also declaring a first-quarter 2026 cash dividend of US$0.17 per share payable on March 19, 2026. Despite higher quarterly revenue and earnings per share, full-year profit was essentially flat and earnings per share fell, raising questions about how effectively Somnigroup is converting its expanding sales base...

Corebridge Financial, the retirement-focused insurer spun off from AIG, recently reported a past-quarter revenue increase of 35.7% year over year, substantially exceeding analyst expectations alongside a strong earnings per share beat. This performance made Corebridge one of the strongest life insurance names on earnings surprise, yet it still appeared to fall short of already elevated investor expectations. Building on this substantial revenue beat, we’ll now examine how the latest results...

Adobe (NasdaqGS:ADBE) is facing rising competitive pressure from generative AI tools and rivals such as Figma. The company is rolling out its own generative AI products, including Firefly, across its creative software suite. Adobe is also signing new enterprise partnerships that aim to keep its tools embedded in large customer workflows. Adobe sits at the center of the creative software market, with products that many graphic designers, marketers, and content creators rely on every day...

If you are wondering whether Honeywell International's current share price is giving you good value or asking too much, you are not alone. The stock last closed at US$242.20, with recent returns of 0.4% over 7 days, 9.5% over 30 days, 23.6% year to date, 24.3% over 1 year and 41.4% over 3 years, compared with 36.9% over 5 years. Recent headlines around Honeywell have focused on its position as a large industrial and technology group, with ongoing attention on how it is exposed to areas like...

Event-driven snapshot of IES Holdings IES Holdings (IESC) has drawn fresh attention after a recent move in its share price, with the stock last closing at $504.67. This has prompted investors to reassess what the current valuation implies. See our latest analysis for IES Holdings. The recent 1 day share price decline of 1.7% comes after a period of strong momentum, with 30 day and 90 day share price returns of 7.8% and 20% respectively, and a very large 1 year total shareholder return...

In February 2026, EnergyHub and Rivian announced a partnership to give Rivian drivers across North America access to utility-managed EV charging programs that enable both passive and active managed charging as part of EnergyHub’s virtual power plant platform. This collaboration links Rivian’s direct engagement with its vehicle owners to grid-aware charging technology, potentially enhancing the ownership experience while positioning Rivian’s vehicles as flexible grid resources alongside other...